Genotype-phenotype correlations in PRPH2-associated retinal dystrophy
Nocturnal hypoxia: An unrecognised risk factor for neovascular age-related macular degeneration
Towards a personalised approach to predicting and preventing progression of age-related macular degeneration
Exploring exosomal therapeutics delivery strategies for macular disease
Reducing the risk of end-stage complications of neovascular age-related macular degeneration: macular atrophy and subretinal fibrosis
Driving into the future: strategies to enhance independence for drivers with macular degeneration, including licensing options and the role of modern vehicle technology
Macular Disease Foundation Australia welcomes Federal Government’s decision to keep sight-saving eye injections accessible on private health insurance.
Macular Disease Foundation Australia (MDFA) has awarded more than $1 million to eight groundbreaking research
We’re pleased to share the latest edition of our Vision Voice newsletter, where we highlight